Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.

× No keyword cloud information.

5 in total

Review 1. Tumour-induced osteomalacia.

Authors: Salvatore Minisola; Munro Peacock; Seijii Fukumoto; Cristiana Cipriani; Jessica Pepe; Sri Harsha Tella; Michael T Collins
Journal: Nat Rev Dis Primers Date: 2017-07-13 Impact factor: 52.329

Review 2. Regulation and function of the FGF23/klotho endocrine pathways.

Authors: Aline Martin; Valentin David; L Darryl Quarles
Journal: Physiol Rev Date: 2012-01 Impact factor: 37.312

3. Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.

Authors: Clemens Bergwitz; Michael T Collins; Ravi S Kamath; Andrew E Rosenberg
Journal: N Engl J Med Date: 2011-10-27 Impact factor: 91.245

4. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.

Authors: Jen-Chieh Lee; Sheng-Yao Su; Chun A Changou; Rong-Sen Yang; Keh-Sung Tsai; Michael T Collins; Eric S Orwoll; Chung-Yen Lin; Shu-Hwa Chen; Shyang-Rong Shih; Cheng-Han Lee; Yoshinao Oda; Steven D Billings; Chien-Feng Li; G Petur Nielsen; Eiichi Konishi; Fredrik Petersson; Thomas O Carpenter; Kesavan Sittampalam; Hsuan-Ying Huang; Andrew L Folpe
Journal: Mod Pathol Date: 2016-07-22 Impact factor: 7.842

5. Tumor localization and biochemical response to cure in tumor-induced osteomalacia.

Authors: William H Chong; Panagiota Andreopoulou; Clara C Chen; James Reynolds; Lori Guthrie; Marilyn Kelly; Rachel I Gafni; Nisan Bhattacharyya; Alison M Boyce; Diala El-Maouche; Diana Ovejero Crespo; Richard Sherry; Richard Chang; Felasfa M Wodajo; Gad B Kletter; Andrew Dwyer; Michael T Collins
Journal: J Bone Miner Res Date: 2013-06 Impact factor: 6.741

5 in total

6 in total

Review 1. Skeletal and extraskeletal disorders of biomineralization.

Authors: Michael T Collins; Gemma Marcucci; Hans-Joachim Anders; Giovanni Beltrami; Jane A Cauley; Peter R Ebeling; Rajiv Kumar; Agnès Linglart; Luca Sangiorgi; Dwight A Towler; Ria Weston; Michael P Whyte; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal: Nat Rev Endocrinol Date: 2022-05-16 Impact factor: 47.564

2. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.

Authors: Juan M Colazo; Joseph A DeCorte; Erin A Gillaspie; Andrew L Folpe; Kathryn M Dahir
Journal: Bone Rep Date: 2020-12-24

Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.

Review 1. Tumour-induced osteomalacia.

Review 2. Regulation and function of the FGF23/klotho endocrine pathways.

3. Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.

4. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.

5. Tumor localization and biochemical response to cure in tumor-induced osteomalacia.

Review 1. Skeletal and extraskeletal disorders of biomineralization.

2. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.

3. Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.

4. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.

5. Rickets guidance: part II-management.

6. Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience.